Pharmaceuticals
GW Pharmaceuticals Continues to See Positive Results from Epidiolex
In early 2016, GW Pharmaceuticals published the results of the first phase of their study on a CBD-based medicine, which is being…
CBD Hemp Oil Market In 2022 : Increasing Demand In Pharmaceuticals Industry, Food … – Xaralite
CBD Hemp Oil Market Insights 2022 : Pure CBD hemp oil is extracted from the cannabis varieties that are naturally abundant in…
4 Green Flags For Jazz Pharmaceuticals' Buyout of GW Pharmaceuticals
There are 36 U.S. states where medical marijuana is legal, so it seems … The oral spray, which contains both CBD and…
Cannabis Pharmaceuticals Market Key Vendors, New market initiatives, Global presence Brand …
Cannabis Pharmaceuticals Market research report delivers a comprehensive study on production capacity, consumption, import and export for all ……
Cannabis Pharmaceuticals Industry 2020 Market Share, Manufacturers, Size, Growth, Supply …
Cannabis Pharmaceuticals Market 2020 Industry research report represents the historical overview of current market situation and forecast 2026….
MGC Pharmaceuticals launches latest cannabidiol skincare product
The company claims its Derma Plus range includes proprietary CBD compounds extracted from the cannabis plant produced by the MGC Botanic ……
Pivot Pharmaceuticals Acquires BiPhasix™ Transdermal Drug Delivery Technology
According to research the global medical cannabis market is expected to … Cannabidiol (CBD), and Tetrahydrocannabinol (THC) based Products, ……
ETST Large Market Opportunity CBD pharmaceuticals and nutraceuticals is
$ETST Large Market Opportunity CBD pharmaceuticals and … The North American legal cannabis market stood at ~$7 billion in 2016, with ……
Why GW Pharmaceuticals Could Be a Gold Mine for Growth Investors
Epidiolex, which is a liquid formulation of pure cannabis plant-derived cannabidiol (CBD), has been studied by GW Pharmaceuticals since 2007….
Cannabis Could Be Better For Migraines Than Pharmaceuticals: Study
Researchers from the Interuniversity Center in Florence, Italy found that pills containing both THC and CBD reduced migraine pain by 43.5 percent….
Zynerba Pharmaceuticals Initiates ZYN001 Phase 1 Clinical Program
ZYN001 is a synthetic pro‑drug of THC in a state-of-the-art drug-adhesive … ZYN002, the Company's CBD gel, is the first and only…
Medical Marijuana Treatments by GW Pharmaceuticals
The medication was derived from the cannabis plant and its active cannabinoids include tetrahydrocannabinol (THC) and cannabidiol (CBD)….